|
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
|
|
Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
|
|
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
|
|
El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-27.
|
|
Au SL, Wong CC, Lee JM, et al. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 2012; 56: 622-31.
|
|
Ogawa K, Pitchakarn P, Suzuki S, et al. Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci 2012; 103: 860-7.
|
|
Zhu Q, Wang Z, Hu Y, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 2012; 27: 1660-8.
|
|
Tung EK, Wong BY, Yau TO, et al. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. PLoS One 2012; 7: e36565.
|
|
Gao Q, Zhao YJ, Wang XY, et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res 2012; 72: 3546-56.
|
|
Kanno K, Kanno S, Nitta H, et al. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells. Oncol Rep 2012; 28: 867-73.
|
|
Dass K, Ahmad A, Azmi AS, et al. Evolving role of uPA/ uPAR system in human cancers. Cancer Treat Rev 2008; 34: 122-36.
|
|
Croucher DR, Saunders DN, Lobov S, et al. Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer 2008; 8: 535-45.
|
|
Nordengren J, Fredstorp Lidebring M, Bendahl PO, et al. High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. Int J Cancer 2002; 97: 379-85.
|
|
Champelovier P, Boucard N, Levacher G, et al. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis. Urol Res 2002; 30: 301-9.
|
|
Meijer-van Gelder ME, Look MP, Peters HA, et al. Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease. Cancer Res 2004; 64: 4563-8.
|
|
Smith R, Xue A, Gill A, et al. High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. World J Surg 2007; 31: 493-502.
|
|
Zhou L, Hayashi Y, Itoh T, et al. Expression of urokinase- type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibi-tor-1 and -2 in hepatocellular carcinoma. Pathol Int 2000; 50: 392-7.
|
|
Itoh T, Hayashi Y, Kanamaru T, et al. Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15: 422-30.
|
|
Li Y, Tang ZY, Ye SL, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630-6.
|
|
Dong RC, Zhou RH, Lu FD, et al. Establishment of a human hepatocarcinoma cell line SMMC-7721 and initial observations on its biologic characteristics. Acad J Second Millitary Med Univ 1980; 1: 5-7.
|
|
Varro A, Noble PJ, Pritchard DM, et al. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappaB and RhoA: implications for invasion and apoptosis. Cancer Res 2004; 64: 1695-702.
|
|
Lobov S, Ranson M. Molecular competition between plasminogen activator inhibitors type-1 and -2 for uro- kinase: implications for cellular proteolysis and adhesion in cancer. Cancer Lett 2011; 303: 118-27.
|